Cognitive Genetics Inc.
108 Rotary Drive
Summit, NJ 07901
Biotech and Pharmaceutical
Cognitive Genetics LLC (CogGen) is a pre-commercial consumer healthcare company developing the first pre-symptomatic genetic screening panel for predisposition to the three most common Learning Disabilities (LDs):
Reading Disability (Dyslexia), Specific Language Impairment (SLI) & Speech Sound Disorder (SSD)
CogGen’s proprietary technology combined with it’s unique quantitative modeling allows pre-symptomatic screening resulting in early intervention for those impaired with these common learning disabilities.